Tactile Systems Investor Relations Material
Tactile Systems Technology Inc engages in the development and provision of medical devices for chronic diseases. The company offers Flexitouch Plus system and Entre system, which are pneumatic compression devices that are used to treat lymphedema and chronic venous insufficiency, including venous leg ulcers; AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders; and MediVac Plus system for the management of wounds in hospital settings. Tactile Systems Technology was founded in 1995 and is headquartered in Minneapolis, Minnesota.
Key slides for Tactile Systems Technology Inc
Rubrik's 2024 IPO: What Investors Need To Know
Explore Rubrik's journey to a 2024 IPO, its innovative cybersecurity solutions, and strategic growth, highlighting its impact on the tech sector.
29 Feb 2024
Pricing Power Through Scarcity: A Case Study of Ferrari
Explore how Ferrari's scarcity and brand strength amplify its pricing power, crucial for a luxury company's success.
27 Feb 2024
Jacob Wallenberg: The Chairman of Investor AB
Get to know Jacob Wallenberg, one of the most influential businessmen in Europe and a part of the fifth generation of the Wallenberg family.
28 Feb 2024
🇺🇸 United States